跳至主要内容
临床试验/IRCT20201129049534N4
IRCT20201129049534N4已完成3 期

Evaluation of the effectiveness of curcumin-piperine supplementation on inflammatory factors, cardiac biomarkers, atrial fibrillation and clinical outcomes after coronary artery bypass graft surgery (CABG): A randomized double-blind, placebo-controlled, dose–response study

未提供0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 80 years(—)
性别
All

入选标准

  • Age 30-80 years
  • Gastrointestinal normal function and with intestinal or oral nutrition criteria
  • Ejection fraction (EF) above 15%
  • Arrest Time (cardiac resuscitation) 30 to 90 minutes
  • Willingness to participate in the study and complete the consent form before surgery

排除标准

  • Allergy to herbal products such as turmeric and pepper
  • Taking herbal supplements (as a supplement) during 3 months before the operation
  • Need for emergency surgery
  • Requires balloon pump
  • Adding another operation in addition to CABG, like simultaneous valve operation
  • Patients who do not have an indication for intestinal or oral nutrition on the first day of the intervention and are expected to be unable to receive intestinal or oral nutrition in the future
  • Patients with a history of underlying disease such as congenital and immune disorders and pancreatitis
  • Pregnancy and lactation

研究者

发起方
未提供

相似试验